SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021Anthony Etyang, Ambrose Agweyu, Henry Karanja et al.|PLOS Global Public Health|2022Cited by 34
SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022E. Wangeci Kagucia, Ambrose Agweyu, Abdhalah Ziraba et al.|Influenza and Other Respiratory Viruses|2023Cited by 24
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-June 2022EW Kagucia, Ambrose Agweyu, Abdhalah Ziraba et al.|medRxiv|2022Cited by 9
SARS-CoV-2 Seroprevalence in three Kenyan Health and Demographic Surveillance Sites, December 2020-May 2021Anthony Etyang, Ambrose Agweyu, Ifedayo Adetifa et al.|medRxiv|2022Cited by 3
Author response for "SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022"E. Wangeci Kagucia, Ambrose Agweyu, Abdhalah Ziraba et al.|Unknown|2023Cited by 0